Completed |
: Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
: - Brenner Tumor
- Fallopian Tube Cancer
-
- Drug: carboplatin Given intrap
|
Completed |
: Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
: - Brenner Tumor
- Fallopian Tube Cancer
-
- Procedure: adjuvant therapy
- Drug: paclitax
|
Recruiting |
: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
: - Ovarian Brenner Tumor
- Ovarian Carcinosarcoma
-
- Drug: Gemcitabine Hydrochloride
|
Completed |
: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
: - Malignant Ovarian Mixed Epithelial Tumor
- Ovarian Brenner Tumor<
: 2011-02-10
: - Drug: TLR8 Agonist VTX-2337 Gi
|
Suspended |
: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
: - Nausea and Vomiting
- Ovarian Brenner Tumor
-
- Procedure: Adjuvant Therapy An
|
Active, not recruiting |
: Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
: - Malignant Ovarian Mixed Epithelial Tumor
- Ovarian Brenner Tumor<
: 2009-08-01
: - Biological: Bevacizumab Given
|
Completed |
: Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
: - Fallopian Tube Carcinoma
- Malignant Ovarian Mixed Epithelial Tumor
-
- Drug: Carboplatin Given IV
|
Active, not recruiting |
: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
: - Cognitive Side Effects of Cancer Therapy
- Malignant Ovarian Epithelial Tumor
-
- Procedure: Cognitive Assessment
|
Completed |
: A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
: - Fallopian Tube Carcinoma
- Malignant Ovarian Mixed Epithelial Tumor
-
- Biological: Urokinase-Derived Peptide A6
|
Recruiting |
: MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian Cancer
: - Malignant Ovarian Brenner Tumor
- Ovarian Clear Cell Adenocarcino
: 2014-02-19
: - Other: Laboratory Biomarker Analysis
|